Cargando…

Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control

The number of diabetic patients has risen dramatically in recent decades, owing mostly to the rising incidence of type 2 diabetes mellitus (T2DM). Several oral antidiabetic medications are used for the treatment of T2DM including, α-glucosidases inhibitors, biguanides, sulfonylureas, meglitinides, G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Youssef, Mahmoud E., Yahya, Galal, Popoviciu, Mihaela Simona, Cavalu, Simona, Abd-Eldayem, Marwa A., Saber, Sameh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094124/ https://www.ncbi.nlm.nih.gov/pubmed/37047011 http://dx.doi.org/10.3390/ijms24076039

Ejemplares similares

Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice
por: Youssef, Mahmoud E., et al.
Publicado: (2023)

Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials
por: Popoviciu, Mihaela-Simona, et al.
Publicado: (2023)

Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities
por: Popoviciu, Mihaela Simona, et al.
Publicado: (2023)

Identification of Natural Lead Compounds against Hemagglutinin-Esterase Surface Glycoprotein in Human Coronaviruses Investigated via MD Simulation, Principal Component Analysis, Cross-Correlation, H-Bond Plot and MMGBSA
por: Ali, Iqra, et al.
Publicado: (2023)

COVID-19 surveillance in wastewater: An epidemiological tool for the monitoring of SARS-CoV-2
por: Maryam, Sajida, et al.
Publicado: (2023)

Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
por: Popoviciu, Mihaela Simona, et al.
Publicado: (2023)

Ameliorative Effect of Dabigatran on CFA-Induced Rheumatoid Arthritis via Modulating Kallikrein-Kinin System in Rats
por: Youssef, Mahmoud E., et al.
Publicado: (2022)

Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
por: Sayour, Alex Ali, et al.
Publicado: (2021)

Designing New Sport Supplements Based on Aronia melanocarpa and Bee Pollen to Enhance Antioxidant Capacity and Nutritional Value
por: Tirla, Adrian, et al.
Publicado: (2023)

Unlocking the potential: Expanding plastid transformation for beyond-organelle function
por: Liu, Peng
Publicado: (2023)

Acute Hepatitis of Unknown Origin in Pediatric Age Group: Recent Outbreaks and Approach to Management
por: Patel, Neil, et al.
Publicado: (2022)

SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
por: Androutsakos, Theodoros, et al.
Publicado: (2022)

Broken Heart Syndrome: Evolving Molecular Mechanisms and Principles of Management
por: Sethi, Yashendra, et al.
Publicado: (2022)

The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection
por: Brown, Emily, et al.
Publicado: (2021)

Evaluation of the Corneal Endothelium Following Cataract Surgery in Diabetic and Non-Diabetic Patients
por: Ciorba, Adela-Laura, et al.
Publicado: (2023)

Regulatory and pathogenic mechanisms in response to iron deficiency and excess in fungi
por: Pijuan, Jordi, et al.
Publicado: (2023)

Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring
por: Maryam, Sajida, et al.
Publicado: (2023)

Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics
por: Haq, Ihtisham Ul, et al.
Publicado: (2023)

Blocking prostanoid receptors switches on multiple immune responses and cascades of inflammatory signaling against larval stages in snail fever
por: Saber, Sameh, et al.
Publicado: (2022)

Unlocking the full potential of probiotics: refocusing on microbial demands
por: Joossens, Marie
Publicado: (2020)

Exploring the Cardiovascular Benefits of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: Expanding Horizons Beyond Diabetes Management
por: Fatima, Aroob, et al.
Publicado: (2023)

CETP and SGLT2 inhibitor combination therapy improves glycemic control
por: Khomtchouk, Bohdan B., et al.
Publicado: (2023)

Multidisciplinarity Is Critical to Unlock the Full Potential of Modern Light Microscopy
por: Weber, Michael, et al.
Publicado: (2021)

Options for the beginner and beyond: unlock the opportunities and minimize the risks
por: Olmstead, W Edward
Publicado: (2006)

Flu Hunter: Unlocking the Secrets of a Virus
por: Boktor, Sameh W., et al.
Publicado: (2019)

Advantages of Cubosomal Formulation for Gatifloxacin Delivery in the Treatment of Bacterial Keratitis: In Vitro and In Vivo Approach Using Clinical Isolate of Methicillin-Resistant Staphylococcus aureus
por: Nasr, Mohamed, et al.
Publicado: (2022)

Mouse Models with SGLT2 Mutations: Toward Understanding the Role of SGLT2 beyond Glucose Reabsorption
por: Unno, Keiko, et al.
Publicado: (2023)

SGLT2i: beyond the glucose-lowering effect
por: Ni, Lihua, et al.
Publicado: (2020)

Sodium-glucose Co-transporter-2 inhibitors (SGLT2I): A class of drugs with promising cardiorenal protective effects beyond glycemic control
por: Zaawari, Abdullah, et al.
Publicado: (2022)

EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors
por: Fernández-Fernandez, Beatriz, et al.
Publicado: (2023)

Unlocking the potential of DNA-based tagging: current market solutions and expanding horizons
por: Kuzdraliński, Adam, et al.
Publicado: (2023)

Benefits of SGLT2 Inhibitor: Preventing Heart Failure and Beyond
por: Kim, Yong Sook, et al.
Publicado: (2019)

A spin-off company helps to unlock the full potential of Invenio software
por: Andrew Purcell
Publicado: (2015)

Unlocking autofluorescence in the era of full spectrum analysis: Implications for immunophenotype discovery projects
por: Jameson, Vanta J., et al.
Publicado: (2022)

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations
por: Yau, Kevin, et al.
Publicado: (2022)

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations
por: Yau, Kevin, et al.
Publicado: (2022)

Combining Gold Nanoparticles with Other Radiosensitizing Agents for Unlocking the Full Potential of Cancer Radiotherapy
por: Alhussan, Abdulaziz, et al.
Publicado: (2021)

Unlocking full and fast conversion in photocatalytic carbon dioxide reduction for applications in radio-carbonylation
por: Monticelli, Serena, et al.
Publicado: (2023)

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial
por: Zambrowicz, B, et al.
Publicado: (2012)

SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes
por: Herat, Lakshini Yasaswi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uh8qh0dal4pqvu9qqcnb7bbf8s